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successful in 10 out of 24 studies with generally small increases in adherence up to a maximum of 23 per cent. Complex interventions involving more than one technique increased adherence in eight out of 18 studies, ranging from 5 per cent to a maximum of 41 per cent. Patient education alone seemed largely unsuccessful.
Authors' conclusions
Reducing the number of daily doses appears to be effective in increasing adherence to blood pressure lowering medication and should be tried as a first line strategy, although there is less evidence of an effect on blood pressure reduction. Some motivational strategies and complex interventions appear promising, but we need more evidence on their effect through carefully designed RCTs.
P L A I N L A N G U A G E S U M M A R Y

What interventions improve adherence to treatment in patients with high blood pressure in ambulatory settings
High blood pressure is a major risk factor for heart attack and stroke, and drug treatment of high blood pressure can substantially reduce this risk. However, the control of high blood pressure in the community is far from optimal. One of the major reasons for this is that patients with high blood pressure often fail to take their medication as prescribed. A number of interventions have been tested that aim to help patients take their medication but it is still uncertain how effective they are.
This review evaluates the effectiveness of interventions aiming to help patients with taking blood pressure lowering medication. We included studies in adult patients with a diagnosis of high blood pressure in a community setting and assessed interventions that aimed to increase adherence to blood pressure lowering medication. The outcomes assessed were adherence to medication and blood pressure changes.
For many interventions it is difficult to draw any real conclusions due to weaknesses of the included studies. However, reducing the number of daily doses appears to be effective in increasing adherence to blood pressure lowering medication and should be tried as a first line strategy although there is little evidence of an effect on blood pressure reduction. Some motivational strategies and complex interventions appear promising but we need more evidence on their effect through carefully designed randomised controlled trials to confirm these findings.
B A C K G R O U N D
Hypertension is a major risk factor in the development of cardiovascular disease and poses a significant public health problem (MacMahon 1990) . Randomized trials have demonstrated that treating high blood pressure with medication can substantially reduce the risk of stroke by 31 to 45 per cent and myocardial infarction by 8 to 23 per cent (Collins 1994) . There is evidence that intensification of medication by means of treatment with two or more antihypertensive drugs is associated with improved blood pressure control (HDFP 1986 , HDFP 1984 . Despite the availability of effective treatments, the control of high blood pressure in the community is far from optimal, with lack of adherence to blood pressure lowering medication being a major factor (Burt 1995 , Colhoun 1994 , Sackett 1975 . Adherence in treated hypertensives is estimated to be between 50 to 70 per cent (Psaty 1990 , Caro 1995 , and the importance of improving adherence to longterm therapies has recently been addressed by the World Health Organization in a major report (Sabate 2003) .
A variety of interventions aiming to improve adherence to antihypertensive medication have been evaluated in randomized controlled trials (RCTs), and five systematic reviews have tried to summarize the evidence in this field (Dunbar-Jacob 1991; Ebrahim 1998 , Morrison 2000 , McDonald 2002 , Roter 1998 . The searches in three of these reviews were limited to studies indexed only in MEDLINE (Dunbar-Jacob 1991 , Ebrahim 1998 , Morrison 2000 , thereby lacking in sensitivity and specificity (Dickersin 1994) and only included English language publications. None of these reviews could recommend any single approaches that increase adherence to blood pressure lowering medication. The most recent and more general review used a more comprehensive literature search and included six studies in hypertension (McDonald 2002 
O B J E C T I V E S
• To locate and describe studies evaluating interventions aimed at improving adherence to antihypertensive medication • To undertake a critical review of the quality of the study methods looking in particular at study design and validity • To summarise the effectiveness of the above interventions
• To indicate areas for future research
M E T H O D S
Criteria for considering studies for this review
Types of studies
RCTs of interventions to increase adherence to blood pressure lowering medication.
Types of participants
Adults with a diagnostic label of essential hypertension (as defined in individual studies) in a primary care, outpatient or other community setting.
Types of interventions
Any intervention designed to enhance medication adherence, including the following: 1. Education of caregivers and patients (e.g. counselling, health education) 2. Simplification of dosage regimens 3. Involvement of allied health professionals (e.g. nurses, pharmacists) 4. Special monitoring (e.g. vial caps, blood pressure self-measurement) 5. Motivation (e.g. financial incentives, reminder packages, reminder aids including diaries or follow-up appointments) Control groups should either have received no intervention or "usual care" and have similar characteristics as the intervention groups.
Types of outcome measures
1. Adherence to medication (including any definition of adherence and noting how this was defined and measured in each study) 2. Blood pressure change in mmHg or change in blood pressure control according to the criteria used in each individual RCT. A 'net reduction' of blood pressure refers to the 'net' difference between the changes of blood pressure between baseline and followup in the intervention and control group. Exclusion criteria: 1. Interventions not designed to increase adherence 2. Participants suffering from secondary hypertension 3. Participants hospitalised as opposed to ambulatory 4. Study design not RCT 5. Results already reported in another publication 6. Full results not reported and further information not available from study authors
Search methods for identification of studies
We identified original RCTs by an all-language search of all articles (any year) in the Cochrane Controlled Trials Register (CCTR), which now includes all RCTs that can be found in the MEDLINE and EMBASE databases, in April 2002. We applied a systematic search strategy using a series of topic terms to define the condition of interest (see below). We screened the references of all retrieved articles to identify additional publications. We contacted 25 study authors and experts in the field about other relevant trials or unpublished material and obtained responses from 17 individuals . Search strategy: 1 HYPERTENS* 2 BLOOD-PRESSURE*:ME 3 (BLOOD:TI near PRESSURE:TI) 4 BLOOD-PRESSURE-DETERMINATION*:ME 5 BLOOD:TI next PRESSURE:TI near MONITOR*:TI 6 #1 or #2 or#3 or #4 or #5 7 PATIENT near COMPLIANCE 8 COMPLIANCE and :TI or ADHERENCE:TI 9 PATIENT next EDUCATION 10 ADHER* or MOTIVAT* 11 AMBULATORY-CARE*:ME 12 AMBULATORY:TI 13 COUNSEL* 14 FEEDBACK 15 REMINDER-SYSTEMS*:ME 16 REMIND* 17 DRUG-INFORMATION-SERVICES*:ME 18 ATTITUDE-TO-HEALTH*:ME 19 EDUCATION* next METHODS 20 EDUCATION* next MATERIAL* 21 PUBLICATIONS*:ME 22 PAMPHLET* or BROCHURE* or LEAFLET* or POSTER* 23 #7 or #8 or #9 or #10 or #11 or #12 or #13 or #14 or #15 or #16 or #17 or #18 or #19 or #20 or #21 or #22 24 #6 and #23 This search strategy was amended slightly for further searches of MEDLINE, EMBASE and CINAHL.
Data collection and analysis
Study Identification
We assessed studies according to the Cochrane Handbook. Two investigators (KS, TF) assessed lists of citations and abstracts independently. Each reviewer indicated whether a citation was potentially relevant (i.e. appearing to meet the inclusion criteria), was clearly not relevant, or gave insufficient information to make a judgement. We resolved differences by discussion and attempted to obtain printed copies of all potentially relevant citations or full paper versions of those where insufficient information was available. Both investigators assessed copies of all presumably relevant articles independently according to the above criteria. To be included in the review, a study had to meet all our selection criteria.
Study Selection
We independently extracted data in duplicate concerning study design, methods, clinicians and patients, interventions, outcomes and potential sources of bias using a structured data collection form. As there is only a small amount of evidence available that masking reviewers reduces the risk of bias, we were not blinded to the source and the authors of publications.(Berlin 1997) A third rater (SE) verified the data extraction, and corrections were made where necessary. Study evaluation Due to the limited evidence on applying quality scores for individual RCTs we have presented RCT characteristics in a descriptive format, thereby providing a more accessible and more objective summary.(Juni 1999) Two reviewers provided data for the table independently and in duplicate, which were verified by the third reviewer. Disagreements were handled in the same way as for study identification and selection. We contacted 25 corresponding authors of studies to request missing data and verification of study details. Quantitative data analysis Due to heterogeneity between studies in terms of interventions and the various methods that were used to measure adherence, we felt that pooling of the results was inappropriate. We grouped and reported the individual arms of factorial trials separately in the respective groups.
R E S U L T S
Description of studies
See: Characteristics of included studies; Characteristics of excluded studies. We screened 1929 citations and included 38 studies that met all our predefined criteria, involving a total of 15519 patients and testing 58 different interventions. The table 'Characteristics of included studies' summarizes the characteristics of included RCTs, which were conducted between 1975 and 2000. We chose to report the interventions tested in factorial trials separately and treated these like individual studies. The majority of trials were performed in the USA (n equals 21) and Canada (n equals 8) with the remainder located in Europe (n equals 8), Australia (n equals 1) and South Africa (n equals 1). Study participants fell into a number of different categories that included newly diagnosed patients, patients with established hypertension on medication, patients with controlled or uncontrolled hypertension, patients adherent or non-adherent to medication or infrequent attendees at clinic. In view of a lack of a generally accepted categorization, we grouped studies arbitrarily into the following four pragmatic categories: (i) simplification of dosing regimens, (ii) patient education, (iii) patient motivation, support and reminders and (iv) complex health and organizational interventions including interventions in combination. Adherence was measured in different ways, including self-report, direct questioning, pill counts, and the medication event monitoring system (MEMS®), which logs the time and date of each opening of a medication container. Various criteria for adherence were used in the different studies. All studies examined both men and women in varying proportions, and the duration of followup ranged from two to 60 months.
Risk of bias in included studies
The methodological quality of included studies was generally low (see Table 1 ). The randomization process was reported and provided adequate concealment of allocation in only 10 out of the 38 studies (26 per cent). The outcome assessors were blind to treatment allocation in 12 studies (31 per cent). Losses to followup were well documented in 33 studies (85 per cent). Only eight trials (21 per cent) reported a power calculation, and most of the remaining trials appeared too small to detect clinically important differences. None of the included studies fulfilled all the quality criteria.
Effects of interventions
EFFECT ON ADHERENCE AND BLOOD PRESSURE Individual RCTs reported results on adherence in many different ways, making a pooled analysis inappropriate. Nineteen studies reported an improvement in adherence alone, of which 13 also reported blood pressure changes. Seven RCTs found an improvement in adherence combined with a reduction in blood pressure, and in seven studies a reduction in blood pressure occurred without an increase in adherence. Fifteen of the included studies (26 per cent) did not report a blood pressure outcome, and none of the studies examined major clinical endpoints. Please note that in the following section, the total number of RCTs (i.e. interventions) is 58 rather than 38. This is because some studies reported the results of factorial trials testing two or more different interventions, which we have evaluated separately.
(i) SIMPLIFICATION OF DOSING REGIMENS (nine study interventions)
Interventions evaluated in this category included once daily versus twice daily preparations of metoprolol, amlodipine, or enalapril. One study tested transdermal clonidine plus placebo tablets versus verapamil and a transdermal placebo (Burris 1991). Asplund and colleagues compared pindolol and clopamide combined in one tablet versus both drugs in separate tablets. Simplifying dosing regimens improved adherence in seven out of nine studies (Andrejak 2000 , Baird 1984 , Boissell 1996 , Detry 1995 , Leenen 1997 , Mounier-Veh. 1998 , Girvin 1999 , with relative improvement in adherence ranging from 8 to 19.6 per cent. All five studies in this category that used objective outcome measurement (MEMS®) showed an improvement in adherence through the use of once-daily instead of twice-daily dosage regimens, although four of these compared two different drugs. Seven studies also reported blood pressure changes. Only one study showed an increase in adherence (90 versus 82 per cent, p less than 0.01) together with a reduction in systolic blood pressure of 6 mmHg systolic (p less than 0.01) (Leenen 1997). However, the changes in diastolic blood pressure in this study were insignificant. (ii) PATIENT EDUCATION (six study interventions) Educational interventions in the included studies consisted of an educational programme via slides, audiotape and booklet (Sackett 1975) , group education (Webb 1980; Pierce 1984; Marquez-Contr. 1998 ), written educational material (Kirscht 1977) , and education via visual aids, lecture, discussion and knowledge test (Kerr 1985) . Patient education seemed largely unsuccessful. Only a single and relatively small trial (n=110) improved adherence (93 versus 69 per cent, p less than 0.002) with no reported effect on blood pressure (Marquez-Contr. 1998 ). This study used group education in groups of 15 people over 90 minutes and additional postal information leaflets at one, three and five months.
(iii) PATIENT MOTIVATION, SUPPORT AND RE-MINDERS (24 study interventions)
In this category, we included interventions such as special compliance dispensers (Becker 1986; Eshelman 1976; Rehder 1980; McKenney 1992; Skaer 1993) , drug reminder charts (Gabriel 1977), self-recording of blood pressure (Johnson 1978; Kirscht 1977; Kerr 1985; Zarnke 1997) , monthly home visits (Johnson 1978) , teaching on self-determination (Nessman 1980), counsel-ing (Rehder 1980; Webb 1980; Morisky 1985; Park 1996) , nurse phone calls (Kirscht 1977) , social support (Kirscht 1977; Morisky 1985) , small group training (Morisky 1985), postal reminders (Skaer 1993), and telephone-linked computer counselling (an interactive computer based telecommunications system that converses with patients in their homes between office visits to their physicians) (Friedman 1996) . Motivational strategies were successful in 10 out of 24 study interventions with mostly small increases in adherence up to a maximum of 23 per cent (Kirscht 1977 , Gabriel 1977 , Nessman 1980 , Friedman 1996 , McKenney 1992 , Morisky 1985 , Skaer 1993 , Kirscht 1977 . All of these studies used methods of measuring adherence, such as pill counts, self-report, direct questioning, and prescription refill records, which are less reliable than electronic monitoring (Urquhart 1997). Successful interventions included daily drug reminder charts (mean adherence score 82.4 versus 70.4 per cent, p=0.002) (Gabriel 1977), training on self-determination (4.6 out of 7 weeks adherent versus 3.3 weeks in the control group, p less than 0.001) (Nessman 1980), reminders and packaging (increase in adherence between 8 per cent for reminders alone and 23 per cent for reminders and packaging in combination, p less than 0.05) (Skaer 1993), social support (98 per cent achieved maximum adherence score versus 93 per cent, p less than 0.05) (Kirscht 1977), nurse phone calls (96 per cent achieved maximum adherence score versus 91 per cent, p less than 0.05) (Kirscht 1977), family member support (53 per cent high adherers versus 40 per cent low adherers, p less than 0.05) (Morisky 1985), electronic medication aid cap (mean adherence 95 per cent versus 78 per cent, p=0.0002) (McKenney 1992), and telephone-linked computer counseling (18 per cent adherent versus 12 per cent in the control group, p=0.03) (Friedman 1996 (Blenkinsopp 2000 , Burrelle 1986 , Logan 1979 , Sclar 1991 , Solomon 1998 , Haynes 1976 , Saunders 1991 , ranging from five per cent to a maximum of 41 per cent. Worksite care through specially trained nurses improved adherence (67 per cent versus 49 per cent, p less than 0.005) and led to a net reduction in diastolic blood pressure of 4 mmHg between intervention and control groups (p less than 0.001) (Logan 1979). A combination of home visits, education and special dosing devices improved adherence in a small trial of 16 patients (92 per cent versus 71 per cent, p less than 0.001) (Burrelle 1986). A strategy involving an educational leaflet, a telephone reminder, a mailed reminder and an educational newsletter was successful in both previously treated hypertensives ('medication possession ratio' 82 per cent versus 48 per cent, p less than 0.05) and those who were newly diagnosed (93 per cent versus 52 per cent, p less than 0.05) (Sclar 1991) . Two fairly recent trials reported weak evidence of an effect of a patientcentered pharmaceutical care model in which pharmacists either used a structured, brief questioning protocol to identify patients' medication related problems and their information needs relating to hypertension and its treatment (compliance score 0.23 versus 0.61, p less than 0.05) (Solomon 1998), or a combination of structured brief questioning protocol with advice, information and referral to the family practitioner (62 per cent adherent versus 50 per cent, p less than 0.05) (Blenkinsopp 2000) . In this study, blood pressure was also better controlled (i.e. blood pressure readings of 159/89 mmHg or below) in the intervention group (35.7 per cent became controlled versus 17.1 per cent, p less than 0.05), although blood pressure data were available only for a subset of participants.
D I S C U S S I O N
Summary of key findings
In this systematic review we found RCTs that evaluated a number of strategies to improve adherence to blood pressure lowering medication, including simplification of dosing regimens, patient education, motivation, support, and reminders as well as complex health and organizational interventions including interventions in combination. Simplification of dosing regimens increased adherence in seven out of nine studies, with improvement in adherence ranging from 8 to 19.6 per cent. Adherence in these studies was mainly measured with electronic monitors and these results confirm findings from past research. There was inconclusive evidence for the effect of motivational and more complex interventions. Education alone appeared largely unsuccessful. An effect on both adherence and blood pressure was only observed in seven out of 58 interventions (18 per cent). While an effect on both adherence and blood pressure was only observed for a minority of interventions, not all studies reported blood pressure outcomes.
INTERPRETATION OF THE RESULTS IN THE LIGHT OF PREVIOUS RESEARCH
This review differs from previously published reviews in that we used a more comprehensive search strategy and different methodology. Compared to the latest reviews on adherence enhancing strategies (Morrison 2000; McDonald 2002) , we found and included considerably more studies (nine and 32 more studies respectively). The review by Morrison extracted categorical data in preference to continuous data and ignored evidence from trials where data could not be converted. This may have been particularly relevant for the results in the group with changes in medication dosing, where we come to the opposite conclusion. This review is also different in that we have reported the results from individual arms of factorial trials separately.
We agree with the review by McDonald et al that for complex interventions it is often difficult to estimate the independent effects of individual interventions (McDonald 2002) . It also remains difficult to disentangle specific adherence effects as opposed to nonspecific effects of increased attention. Our findings confirm that even the most effective interventions do not appear to lead to large improvements in adherence and blood pressure reductions. However, clinical outcomes were not measured and BP measurements were not included in all of the studies.
An earlier review of research on adherence reported benefits of educational interventions in improving adherence (Dunbar-Jacob 1991). However, we were unable to confirm this finding, perhaps because our review was limited to evidence from randomised trials only.
LIMITATIONS OF THIS REVIEW
Comparing the RCTs included in this review was difficult. Many RCTs showed marked heterogeneity in terms of participants, interventions and outcomes. Study authors also measured and reported adherence inconsistently. Individual RCTs demonstrated variable and often poor methodological quality, particularly with regard to randomization, blinding of outcome assessment and losses to follow-up, whilst the sample sizes of many trials were too small to detect clinically relevant differences. Rather surprisingly, 15 out of the included 38 studies (39%) did not report a blood pressure outcome, and none reported major clinical endpoints.
There are also some difficulties in interpreting the results of this systematic review. Adherence was measured (e.g. self-report, pill counts, direct questioning, electronic monitoring, drug blood levels) and calculated in different ways (e.g. using arbitrary cut-off points to define adherence such as 80%), and in addition was usually assessed unblinded to allocation status, which made the comparison of RCTs difficult. Levels of adherence in the control groups of the trials studied ranged from 12% to 94%, which is indicative of the heterogeneity in both criteria for defining adherence and the participants studied. With no agreed definitions on how adherence should be measured and defined, it is not surprising that for most interventions the impact on adherence and blood pressure appears to be variable. Because of the different definitions for adherence that have been adopted in individual RCTs, it has not been possible to examine the relationship between adherence to medication and subsequent blood pressure control. Our categorization and grouping of trials was arbitrary, and the group allocation of some trials might be debatable.
It is possible that the interventions tested in the factorial trials were not independent from each other. Particularly in the case of complex interventions evaluated in factorial trial designs, interactions are likely, and the results have therefore to be interpreted with caution.
A U T H O R S ' C O N C L U S I O N S
Implications for practice
Our findings suggest that introducing simpler dosing regimens can be effective in improving adherence, but the effect on subsequent blood pressure reduction has not been established and may not be clinically important. The results of various motivational and more complex interventions are promising, although there is insufficient evidence to suggest a single approach.
We suggest that innovative approaches should be introduced in the context of further RCTs. It is important that physicians are aware of the various reasons for poor adherence and aim to simplify dosing regimes as far as possible.
Different health professionals were involved in delivering the interventions in the studies included in this review. In many countries, the role of allied health professionals such as nurses or physician assistants is expanding, which may lead to new management opportunities for tackling adherence-related problems in patients with high blood pressure.
Implications for research
The results of this review highlight a number of problem areas in adherence related research. Many studies used unreliable methods of measuring adherence such as self-report and pill counts. It appears that electronic monitoring provides more objective and reliable results and, in addition, produces data on medication taking patterns (Urquhart 1997) . Although a large number of studies have been conducted in this area, larger trials of higher quality are needed that use reliable methods of measuring adherence and that also investigate the relationship between adherence and blood pressure reduction. We feel this is particularly important in the context of an increasing elderly population of people who often take multiple medications.
Hypertensive patients may fail to take their medication due to the long duration of therapy, the symptomless nature of the condition, side effects of medication, complicated drug regimens, lack of understanding about hypertension management, lack of motivation and the challenge to individual patients' health beliefs (Ebrahim 1998; Dowell 2002) . It would seem logical that future studies should try and adopt a 'tailored' approach aimed at individual patients and addressing the above mentioned barriers to adherence (Working Party 1997). Combinations of strategies that include simpler dosage regimens, patient motivation and that in-volve other health professionals in a patient-centered approach should be further investigated. In addition, patients' views should be taken into account when piloting interventions, and the interventions themselves should be based on shared decision-making in a partnership between patient and practitioner (Bowling 2001; Sieber 2000; Thomson 2001; Rand 2000) .
It is paramount that every study that evaluates an intervention to increase adherence to blood pressure lowering medication should also measure blood pressure as a second outcome to help examine the relationship between adherence and blood pressure control.
Finally, only one RCT underwent an economic evaluation, which showed that nurse-led work-site care was not cost-effective, with an incremental cost-effectiveness ratio almost double that of usual care (Logan 1983) . It is important that future studies include economic analyses because adherence interventions will generally have cost implications. Adherence to blood pressure lowering medication must persist long-term to show a clinically relevant benefit. Many studies included in this review had a follow-up period of less than six months (see table of Characteristics of Studies). We therefore suggest that interventions in future studies should be tested over a period of at least six months.
We conclude that simplification of dosing regimens appears to be the most promising intervention to increase adherence to blood pressure lowering medication. The results of this review should be interpreted with caution due to the poor methodological quality and heterogeneity of trials included in this review. Our findings emphasize the need for further RCTs with sufficient power and of rigorous methodology. 
A C K N O W L E D G E M E N T S
C H A R A C T E R I S T I C S O F S T U D I E S
Characteristics of included studies [ordered by study ID]
Andrejak 2000
Methods
Parallel trial, study duration six months, follow -up at six months Outcomes PILL COUNT AND SELF REPORT: better compliance scores in intervention group (0.23) compared to controls (0.61, p less than 0.05). Net blood pressure reduction 6.9 mmHg systolic (p less than 0.05) and minus 0.6 mmHg Solomon 1998 (Continued) diastolic (not statistically significant)
Notes
Only results from self-report of adherence reported. Likelihood of bias
Webb 1980
Methods Parallel three arm, study duration three months, follow-up at 18 months Participants 123 participants with treated hypertension, black, 79 per cent women, mean age 55 years, primary care, USA
Interventions PATIENT EDUCATION AND PATIENT MOTIVATION, SUPPORT AND REMINDERS: education or counselling versus usual care Outcomes PILL COUNT: differences in adherence scores minus 0.2 for education and plus 0.2 for counselling (p greater than 0.10). Net reduction in diastolic blood pressure 3.3 mmHg for education and 2.3 mmHg for counselling (p greater than 0.1, respectively)
Notes
Unclear on which outcome and treatment difference the power calculation was based on, unequal numbers due to drop-outs after randomisation but before start of intervention (no reasons given)
Zarnke 1997
Methods Parallel, study duration eight weeks, follow-up at eight weeks Participants 31 participants with treated and controlled hypertension, 65 per cent women, mean age 54 years, primary care and hospital outpatients, USA Interventions PATIENT MOTIVATION SUPPORT AND REMINDERS: home blood pressure monitoring and self-measurement of blood pressure versus usual care Outcomes NOT CLEARLY DEFINED, PROBABLY PILL COUNT: 0.3 doses missed per subject per week in the intervention group compared to 0.4 in the control group (not statistically significant, no exact p-value reported). Net reduction in mean arterial blood pressure 2.9 mmHg (p equals 0.039)
Notes
No power calculation but primary and secondary hypotheses stated 
Characteristics of excluded studies [ordered by study ID]
W H A T ' S N E W
